ALISSA TUCCIARONE: Open Payments
NPI 1306453022 · NEW HARTFORD, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,649 in 126 payments from 22 companies in 2025. Trend: 2023 $2,474 · 2024 $2,588 · 2025 $2,649
Food & beverage: $2,649
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $551 |
| ABBVIE INC. | 28 | $513 |
| PFIZER INC. | 19 | $212 |
| Novo Nordisk Inc | 13 | $195 |
| Lilly USA, LLC | 13 | $187 |
| LEO Pharma Inc. | 1 | $125 |
| EMD Serono, Inc. | 1 | $125 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $113 |
| GlaxoSmithKline, LLC. | 4 | $76 |
| Amgen Inc. | 4 | $76 |
Products named: AIRSUPRA, VRAYLAR, QULIPTA, FARXIGA, MOUNJARO, ANZUPGO, Mavenclad, NURTEC ODT.
Industry payments across NY — which companies pay providers there.
